SEC Form 4 · accession 0000874015-15-000089
IONIS PHARMACEUTICALS INC · IONS
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
C Frank Bennett
Officer — SVP, Antisense Research
Period of report
Dec 15, 2015
Accepted (ET)
Dec 17, 2015 · 7:23 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000874015
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Dec 15, 2015 | M | 4,000 | $14.47 | A | 11,316 | D | |
| Common StockF1 | Dec 15, 2015 | S | 4,000 | $56.00 | D | 7,316 | D | |
| Common StockF1 | Dec 16, 2015 | M | 3,909 | $14.47 | A | 11,225 | D | |
| Common StockF1 | Dec 16, 2015 | S | 3,909 | $58.85 | D | 7,316 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Employee Stock Option (right to buy) | $14.47 | Dec 15, 2015 | M | 4,000 | D | Jan 2, 2013 | Jan 1, 2016 | Common Stock | 4,000 | 3,909 | D |
| Employee Stock Option (right to buy) | $14.47 | Dec 16, 2015 | M | 3,909 | D | Jan 2, 2013 | Jan 1, 2016 | Common Stock | 3,909 | 0 | D |
Explanation of responses
- F1Acquired as a result of exercising a stock option that was scheduled to expire on 1/1/2016. The purchase and sale reported on this Form 4 was effective pursuant to a Rule 10b5-1 Trading Plan adopted by the reporting person on 2/20/2015.